Revenue
2020
2021
2022
Metabolic Explorer (METEX)
Price—Loading quote
Net income
2020
2021
2022
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2020
2021
2022
Financial statements
| 2022 | 2021 | 2020 | |
|---|---|---|---|
| Revenue | €226.6M | €169.7M | €50,000 |
| Gross profit | −€1.4M | €16.0M | −€1.7M |
| Gross margin | −0.63% | 9.44% | −3,324.00% |
| Research & development | €9.8M | €8.1M | €6.1M |
| Operating expenses | €42.3M | N/A | €8.0M |
| Operating income | −€43.8M | €73.0M | −€9.7M |
| Operating margin | −19.31% | 43.04% | −19,304.00% |
| Net income | −€50.8M | €80.5M | −€9.8M |
| Net profit margin | −22.43% | 47.45% | −19,514.00% |
| Basic EPSper basic share | -€1.16 | €2.25 | -€0.33 |
| Diluted EPSper diluted share | -€1.16 | €2.07 | N/A |
Owners
Reported shareholders and owner groups
25.93%of company shares
SPISource updated Oct 1, 2024
View holders
| Holder | Ownership |
|---|---|
| 25.93%Oct 1, 2024 | |
| 18.85%Oct 1, 2024 | |
| 4.21%Oct 1, 2024 |
These Euronext company-profile figures report shares in the company's capital. Named holders and owner groups are shown as published; free float, treasury shares, and unspecified holders are excluded from the colored segments.
This shareholder table is over two years old; current positions may differ.
Gray completes the 100% scale; it is not an estimate of other owners.
Source: Euronext / Cofisem ↗Checked Oct 21, 2026